BMYBRISTOL MYERS SQUIBB CO
- Market cap
- $125.59B
- as of 2026-10-23
- Latest close
- $61.48
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Drug Manufacturers - General
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2023-10-03
Showing the latest 500 of 793 transactions.
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Gallman CariEVP, General Counsel | Oct 2 | Oct 5 | M | 4,559 | $0.00 | $0 | 18,208 | No | Form 4 |
| Gallman CariEVP, General Counsel | Oct 2 | Oct 5 | F | 2,332 | $61.15 | $142,602 | 15,876 | No | Form 4 |
| Gallman CariEVP, General Counsel | Oct 2 | Oct 5 | M · derivative | 4,559 | $0.00 | $0 | not reported | No | Form 4 |
| Yale Phyllis R | Sep 30 | Oct 2 | A · derivative | 560.9 | $62.40 | $35,000 | 45,980.08 | No | Form 4 |
| Arduini Peter J | Sep 30 | Oct 2 | A · derivative | 560.9 | $62.40 | $35,000 | 74,077.18 | No | Form 4 |
| Rice Derica W | Sep 30 | Oct 2 | A · derivative | 620.99 | $62.40 | $38,750 | 42,084.87 | No | Form 4 |
| McMullen Michael R. | Sep 30 | Oct 2 | A · derivative | 560.9 | $62.40 | $35,000 | 17,050.6 | No | Form 4 |
| Samuels Theodore R. II | Sep 30 | Oct 2 | A · derivative | 821.31 | $62.40 | $51,250 | 71,859.04 | No | Form 4 |
| Massacesi CristianEVP,Chief Med Offr,Head of Dev | Sep 9 | Sep 10 | S | 6,249 | $64.57 | Sale −$403,498 | 18,748 | No | Form 4 |
| Short Bartie WendyEVP, Corporate Affairs | Sep 1 | Sep 3 | M | 1,236 | $66.92 | $82,713 | 13,317 | No | Form 4 |
| Short Bartie WendyEVP, Corporate Affairs | Sep 1 | Sep 3 | F | 633 | $66.92 | $42,360 | 12,684 | No | Form 4 |
| Short Bartie WendyEVP, Corporate Affairs | Sep 1 | Sep 3 | M · derivative | 1,236 | $0.00 | $0 | not reported | No | Form 4 |
| Holzer Phil MSVP and Controller | Aug 25 | Aug 26 | S | 500 | $67.50 | Sale −$33,750 | 16,862 | No | Form 4 |
| Gallman CariEVP, General Counsel | Aug 1 | Aug 4 | M | 1,061 | $0.00 | $0 | 14,192 | No | Form 4 |
| Gallman CariEVP, General Counsel | Aug 1 | Aug 4 | F | 543 | $65.31 | $35,463 | 13,649 | No | Form 4 |
| Gallman CariEVP, General Counsel | Aug 1 | Aug 4 | M · derivative | 1,061 | $0.00 | $0 | not reported | No | Form 4 |
| Massacesi CristianEVP,Chief Med Offr,Head of Dev | Aug 1 | Aug 4 | M | 51,172 | $0.00 | $0 | 51,172 | No | Form 4 |
| Massacesi CristianEVP,Chief Med Offr,Head of Dev | Aug 1 | Aug 4 | F | 26,175 | $65.31 | $1,709,489 | 24,997 | No | Form 4 |
| Massacesi CristianEVP,Chief Med Offr,Head of Dev | Aug 1 | Aug 4 | M · derivative | 51,172 | $0.00 | $0 | 153,519 | No | Form 4 |
| Yale Phyllis R | Jun 30 | Jul 2 | A · derivative | 607.43 | $57.62 | $35,000 | 44,986.29 | No | Form 4 |
| Arduini Peter J | Jun 30 | Jul 2 | A · derivative | 607.43 | $57.62 | $35,000 | 72,815.6 | No | Form 4 |
| Rice Derica W | Jun 30 | Jul 2 | A · derivative | 672.51 | $57.62 | $38,750 | 41,068.68 | No | Form 4 |
| McMullen Michael R. | Jun 30 | Jul 2 | A · derivative | 607.43 | $57.62 | $35,000 | 16,332.54 | No | Form 4 |
| Samuels Theodore R. II | Jun 30 | Jul 2 | A · derivative | 889.45 | $57.62 | $51,250 | 70,360.66 | No | Form 4 |
| Haller Julia A | Jun 15 | Jun 16 | M | 20,460 | $53.76 | $1,099,930 | 34,079 | No | Form 4 |
| Haller Julia A | Jun 15 | Jun 16 | M · derivative | 20,460 | $53.76 | $1,099,930 | not reported | No | Form 4 |
| Short Bartie WendyEVP, Corporate Affairs | Jun 3 | Jun 5 | M | 8,040 | $0.00 | $0 | 15,957 | No | Form 4 |
| Short Bartie WendyEVP, Corporate Affairs | Jun 3 | Jun 5 | F | 3,876 | $54.72 | $212,095 | 12,081 | No | Form 4 |
| Short Bartie WendyEVP, Corporate Affairs | Jun 3 | Jun 5 | M · derivative | 8,040 | $0.00 | $0 | 8,040 | No | Form 4 |
| Lenkowsky AdamEVP, Chief Commercial Officer | May 1 | May 5 | M | 1,373 | $0.00 | $0 | 20,508 | No | Form 4 |
| Lenkowsky AdamEVP, Chief Commercial Officer | May 1 | May 5 | J | 203 | $0.00 | $0 | 20,305 | No | Form 4 |
| Lenkowsky AdamEVP, Chief Commercial Officer | May 1 | May 5 | F | 599 | $58.22 | $34,874 | 19,706 | No | Form 4 |
| Lenkowsky AdamEVP, Chief Commercial Officer | May 1 | May 5 | M · derivative | 1,373 | $0.00 | $0 | 1,375 | No | Form 4 |
| Elkins David VEVP, Chief Financial Officer | Apr 1 | Apr 2 | S | 25,519 | $61.60 | Sale −$1,571,970 | 163,729 | No | Form 4 |
| Elkins David VEVP, Chief Financial Officer | Apr 1 | Apr 2 | S | 4,481 | $62.05 | Sale −$278,046 | 159,248 | No | Form 4 |
| Shanahan KarinEVP, Chief Supply Chain & Ops | Apr 1 | Apr 2 | M | 3,307 | $0.00 | $0 | 27,580 | No | Form 4 |
| Shanahan KarinEVP, Chief Supply Chain & Ops | Apr 1 | Apr 2 | F | 1,692 | $61.73 | $104,447 | 25,888 | No | Form 4 |
| Shanahan KarinEVP, Chief Supply Chain & Ops | Apr 1 | Apr 2 | M · derivative | 3,307 | $0.00 | $0 | not reported | No | Form 4 |
| Yale Phyllis R | Mar 31 | Apr 2 | A · derivative | 577.08 | $60.65 | $35,000 | 43,903.78 | No | Form 4 |
| Arduini Peter J | Mar 31 | Apr 2 | A · derivative | 577.08 | $60.65 | $35,000 | 71,435.17 | No | Form 4 |
| Rice Derica W | Mar 31 | Apr 2 | A · derivative | 638.91 | $60.65 | $38,750 | 39,963.72 | No | Form 4 |
| McMullen Michael R. | Mar 31 | Apr 2 | A · derivative | 577.08 | $60.65 | $35,000 | 15,556.77 | No | Form 4 |
| Samuels Theodore R. II | Mar 31 | Apr 2 | A · derivative | 845.01 | $60.65 | $51,250 | 68,727.52 | No | Form 4 |
| Elkins David VEVP, Chief Financial Officer | Mar 10 | Mar 12 | M | 7,654 | $0.00 | $0 | 175,033 | No | Form 4 |
| Elkins David VEVP, Chief Financial Officer | Mar 10 | Mar 12 | J | 860 | $0.00 | $0 | 174,173 | No | Form 4 |
| Elkins David VEVP, Chief Financial Officer | Mar 10 | Mar 12 | F | 2,883 | $60.13 | $173,355 | 171,290 | No | Form 4 |
| Elkins David VEVP, Chief Financial Officer | Mar 10 | Mar 12 | M | 7,904 | $0.00 | $0 | 179,194 | No | Form 4 |
| Elkins David VEVP, Chief Financial Officer | Mar 10 | Mar 12 | J | 854 | $0.00 | $0 | 178,340 | No | Form 4 |
| Elkins David VEVP, Chief Financial Officer | Mar 10 | Mar 12 | F | 2,991 | $60.13 | $179,849 | 175,349 | No | Form 4 |
| Elkins David VEVP, Chief Financial Officer | Mar 10 | Mar 12 | M | 47,424 | $0.00 | $0 | 222,773 | No | Form 4 |
| Elkins David VEVP, Chief Financial Officer | Mar 10 | Mar 12 | J | 23,285 | $0.00 | $0 | 199,488 | No | Form 4 |
| Elkins David VEVP, Chief Financial Officer | Mar 10 | Mar 12 | F | 10,240 | $60.13 | $615,731 | 189,248 | No | Form 4 |
| Elkins David VEVP, Chief Financial Officer | Mar 10 | Mar 12 | M · derivative | 7,654 | $0.00 | $0 | not reported | No | Form 4 |
| Elkins David VEVP, Chief Financial Officer | Mar 10 | Mar 12 | M · derivative | 7,904 | $0.00 | $0 | 7,904 | No | Form 4 |
| Elkins David VEVP, Chief Financial Officer | Mar 10 | Mar 12 | M · derivative | 47,424 | $0.00 | $0 | not reported | No | Form 4 |
| Elkins David VEVP, Chief Financial Officer | Mar 10 | Mar 12 | A · derivative | 35,265 | $0.00 | $0 | 35,265 | No | Form 4 |
| Elkins David VEVP, Chief Financial Officer | Mar 10 | Mar 12 | A · derivative | 52,898 | $0.00 | $0 | 52,898 | No | Form 4 |
| Boerner Christopher S.Chief Executive Officer | Mar 10 | Mar 12 | M | 6,618 | $0.00 | $0 | 7,800 | No | Form 4 |
| Boerner Christopher S.Chief Executive Officer | Mar 10 | Mar 12 | J | 743 | $0.00 | $0 | 7,057 | No | Form 4 |
| Boerner Christopher S.Chief Executive Officer | Mar 10 | Mar 12 | F | 3,006 | $60.13 | $180,751 | 4,051 | No | Form 4 |
| Boerner Christopher S.Chief Executive Officer | Mar 10 | Mar 12 | M | 6,733 | $0.00 | $0 | 10,784 | No | Form 4 |
| Boerner Christopher S.Chief Executive Officer | Mar 10 | Mar 12 | J | 727 | $0.00 | $0 | 10,057 | No | Form 4 |
| Boerner Christopher S.Chief Executive Officer | Mar 10 | Mar 12 | F | 3,073 | $60.13 | $184,779 | 6,984 | No | Form 4 |
| Boerner Christopher S.Chief Executive Officer | Mar 10 | Mar 12 | M | 40,398 | $0.00 | $0 | 47,382 | No | Form 4 |
| Boerner Christopher S.Chief Executive Officer | Mar 10 | Mar 12 | J | 19,835 | $0.00 | $0 | 27,547 | No | Form 4 |
| Boerner Christopher S.Chief Executive Officer | Mar 10 | Mar 12 | F | 10,518 | $60.13 | $632,447 | 17,029 | No | Form 4 |
| Boerner Christopher S.Chief Executive Officer | Mar 10 | Mar 12 | M | 17,788 | $0.00 | $0 | 34,817 | No | Form 4 |
| Boerner Christopher S.Chief Executive Officer | Mar 10 | Mar 12 | J | 8,734 | $0.00 | $0 | 26,083 | No | Form 4 |
| Boerner Christopher S.Chief Executive Officer | Mar 10 | Mar 12 | F | 4,632 | $60.13 | $278,522 | 21,451 | No | Form 4 |
| Boerner Christopher S.Chief Executive Officer | Mar 10 | Mar 12 | M · derivative | 6,618 | $0.00 | $0 | not reported | No | Form 4 |
| Boerner Christopher S.Chief Executive Officer | Mar 10 | Mar 12 | M · derivative | 6,733 | $0.00 | $0 | 6,733 | No | Form 4 |
| Boerner Christopher S.Chief Executive Officer | Mar 10 | Mar 12 | M · derivative | 40,398 | $0.00 | $0 | not reported | No | Form 4 |
| Boerner Christopher S.Chief Executive Officer | Mar 10 | Mar 12 | M · derivative | 17,788 | $0.00 | $0 | not reported | No | Form 4 |
| Boerner Christopher S.Chief Executive Officer | Mar 10 | Mar 12 | A · derivative | 104,490 | $0.00 | $0 | 104,490 | No | Form 4 |
| Boerner Christopher S.Chief Executive Officer | Mar 10 | Mar 12 | A · derivative | 156,735 | $0.00 | $0 | 156,735 | No | Form 4 |
| Hickey BenjaminPresident, RayzeBio Org. | Mar 10 | Mar 12 | A · derivative | 11,429 | $0.00 | $0 | 11,429 | No | Form 4 |
| Hickey BenjaminPresident, RayzeBio Org. | Mar 10 | Mar 12 | A · derivative | 17,143 | $0.00 | $0 | 17,143 | No | Form 4 |
| Plenge Robert MEVP, Chief Research Officer | Mar 10 | Mar 12 | M | 1,107 | $0.00 | $0 | 16,946 | No | Form 4 |
| Plenge Robert MEVP, Chief Research Officer | Mar 10 | Mar 12 | J | 124 | $0.00 | $0 | 16,822 | No | Form 4 |
| Plenge Robert MEVP, Chief Research Officer | Mar 10 | Mar 12 | F | 436 | $60.13 | $26,217 | 16,386 | No | Form 4 |
| Plenge Robert MEVP, Chief Research Officer | Mar 10 | Mar 12 | M | 2,342 | $0.00 | $0 | 18,728 | No | Form 4 |
| Plenge Robert MEVP, Chief Research Officer | Mar 10 | Mar 12 | J | 253 | $0.00 | $0 | 18,475 | No | Form 4 |
| Plenge Robert MEVP, Chief Research Officer | Mar 10 | Mar 12 | F | 927 | $60.13 | $55,741 | 17,548 | No | Form 4 |
| Plenge Robert MEVP, Chief Research Officer | Mar 10 | Mar 12 | M | 14,052 | $0.00 | $0 | 31,600 | No | Form 4 |
| Plenge Robert MEVP, Chief Research Officer | Mar 10 | Mar 12 | J | 6,900 | $0.00 | $0 | 24,700 | No | Form 4 |
| Plenge Robert MEVP, Chief Research Officer | Mar 10 | Mar 12 | F | 3,172 | $60.13 | $190,732 | 21,528 | No | Form 4 |
| Plenge Robert MEVP, Chief Research Officer | Mar 10 | Mar 12 | M · derivative | 1,107 | $0.00 | $0 | not reported | No | Form 4 |
| Plenge Robert MEVP, Chief Research Officer | Mar 10 | Mar 12 | M · derivative | 2,342 | $0.00 | $0 | 2,342 | No | Form 4 |
| Plenge Robert MEVP, Chief Research Officer | Mar 10 | Mar 12 | M · derivative | 14,052 | $0.00 | $0 | not reported | No | Form 4 |
| Plenge Robert MEVP, Chief Research Officer | Mar 10 | Mar 12 | A · derivative | 17,959 | $0.00 | $0 | 17,959 | No | Form 4 |
| Plenge Robert MEVP, Chief Research Officer | Mar 10 | Mar 12 | A · derivative | 26,939 | $0.00 | $0 | 26,939 | No | Form 4 |
| Meyers Gregory ScottEVP, Chief Digital & Tech Off. | Mar 10 | Mar 12 | M | 2,839 | $0.00 | $0 | 24,267 | No | Form 4 |
| Meyers Gregory ScottEVP, Chief Digital & Tech Off. | Mar 10 | Mar 12 | J | 319 | $0.00 | $0 | 23,948 | No | Form 4 |
| Meyers Gregory ScottEVP, Chief Digital & Tech Off. | Mar 10 | Mar 12 | F | 1,069 | $60.13 | $64,279 | 22,879 | No | Form 4 |
| Meyers Gregory ScottEVP, Chief Digital & Tech Off. | Mar 10 | Mar 12 | M | 3,293 | $0.00 | $0 | 26,172 | No | Form 4 |
| Meyers Gregory ScottEVP, Chief Digital & Tech Off. | Mar 10 | Mar 12 | J | 356 | $0.00 | $0 | 25,816 | No | Form 4 |
| Meyers Gregory ScottEVP, Chief Digital & Tech Off. | Mar 10 | Mar 12 | F | 1,246 | $60.13 | $74,922 | 24,570 | No | Form 4 |
| Meyers Gregory ScottEVP, Chief Digital & Tech Off. | Mar 10 | Mar 12 | M | 19,760 | $0.00 | $0 | 44,330 | No | Form 4 |
| Meyers Gregory ScottEVP, Chief Digital & Tech Off. | Mar 10 | Mar 12 | J | 9,702 | $0.00 | $0 | 34,628 | No | Form 4 |
| Meyers Gregory ScottEVP, Chief Digital & Tech Off. | Mar 10 | Mar 12 | F | 4,267 | $60.13 | $256,575 | 30,361 | No | Form 4 |
| Meyers Gregory ScottEVP, Chief Digital & Tech Off. | Mar 10 | Mar 12 | M · derivative | 2,839 | $0.00 | $0 | not reported | No | Form 4 |
| Meyers Gregory ScottEVP, Chief Digital & Tech Off. | Mar 10 | Mar 12 | M · derivative | 3,293 | $0.00 | $0 | 3,294 | No | Form 4 |
| Meyers Gregory ScottEVP, Chief Digital & Tech Off. | Mar 10 | Mar 12 | M · derivative | 19,760 | $0.00 | $0 | not reported | No | Form 4 |
| Meyers Gregory ScottEVP, Chief Digital & Tech Off. | Mar 10 | Mar 12 | A · derivative | 26,122 | $0.00 | $0 | 26,122 | No | Form 4 |
| Meyers Gregory ScottEVP, Chief Digital & Tech Off. | Mar 10 | Mar 12 | A · derivative | 39,184 | $0.00 | $0 | 39,184 | No | Form 4 |
| Shanahan KarinEVP, Chief Supply Chain & Ops | Mar 10 | Mar 12 | M | 2,448 | $0.00 | $0 | 19,313 | No | Form 4 |
| Shanahan KarinEVP, Chief Supply Chain & Ops | Mar 10 | Mar 12 | J | 275 | $0.00 | $0 | 19,038 | No | Form 4 |
| Shanahan KarinEVP, Chief Supply Chain & Ops | Mar 10 | Mar 12 | F | 1,112 | $60.13 | $66,865 | 17,926 | No | Form 4 |
| Shanahan KarinEVP, Chief Supply Chain & Ops | Mar 10 | Mar 12 | M | 3,293 | $0.00 | $0 | 21,219 | No | Form 4 |
| Shanahan KarinEVP, Chief Supply Chain & Ops | Mar 10 | Mar 12 | J | 356 | $0.00 | $0 | 20,863 | No | Form 4 |
| Shanahan KarinEVP, Chief Supply Chain & Ops | Mar 10 | Mar 12 | F | 1,503 | $60.13 | $90,375 | 19,360 | No | Form 4 |
| Shanahan KarinEVP, Chief Supply Chain & Ops | Mar 10 | Mar 12 | M | 19,760 | $0.00 | $0 | 39,120 | No | Form 4 |
| Shanahan KarinEVP, Chief Supply Chain & Ops | Mar 10 | Mar 12 | J | 9,702 | $0.00 | $0 | 29,418 | No | Form 4 |
| Shanahan KarinEVP, Chief Supply Chain & Ops | Mar 10 | Mar 12 | F | 5,145 | $60.13 | $309,369 | 24,273 | No | Form 4 |
| Shanahan KarinEVP, Chief Supply Chain & Ops | Mar 10 | Mar 12 | M · derivative | 2,448 | $0.00 | $0 | not reported | No | Form 4 |
| Shanahan KarinEVP, Chief Supply Chain & Ops | Mar 10 | Mar 12 | M · derivative | 3,293 | $0.00 | $0 | 3,294 | No | Form 4 |
| Shanahan KarinEVP, Chief Supply Chain & Ops | Mar 10 | Mar 12 | M · derivative | 19,760 | $0.00 | $0 | not reported | No | Form 4 |
| Shanahan KarinEVP, Chief Supply Chain & Ops | Mar 10 | Mar 12 | A · derivative | 21,224 | $0.00 | $0 | 21,224 | No | Form 4 |
| Shanahan KarinEVP, Chief Supply Chain & Ops | Mar 10 | Mar 12 | A · derivative | 31,837 | $0.00 | $0 | 31,837 | No | Form 4 |
| Lenkowsky AdamEVP, Chief Commercial Officer | Mar 10 | Mar 12 | M | 1,828 | $0.00 | $0 | 14,267 | No | Form 4 |
| Lenkowsky AdamEVP, Chief Commercial Officer | Mar 10 | Mar 12 | J | 205 | $0.00 | $0 | 14,062 | No | Form 4 |
| Lenkowsky AdamEVP, Chief Commercial Officer | Mar 10 | Mar 12 | F | 831 | $60.13 | $49,968 | 13,231 | No | Form 4 |
| Lenkowsky AdamEVP, Chief Commercial Officer | Mar 10 | Mar 12 | M | 2,000 | $0.00 | $0 | 15,231 | No | Form 4 |
| Lenkowsky AdamEVP, Chief Commercial Officer | Mar 10 | Mar 12 | J | 216 | $0.00 | $0 | 15,015 | No | Form 4 |
| Lenkowsky AdamEVP, Chief Commercial Officer | Mar 10 | Mar 12 | F | 913 | $60.13 | $54,899 | 14,102 | No | Form 4 |
| Lenkowsky AdamEVP, Chief Commercial Officer | Mar 10 | Mar 12 | M | 12,002 | $0.00 | $0 | 26,104 | No | Form 4 |
| Lenkowsky AdamEVP, Chief Commercial Officer | Mar 10 | Mar 12 | J | 5,893 | $0.00 | $0 | 20,211 | No | Form 4 |
| Lenkowsky AdamEVP, Chief Commercial Officer | Mar 10 | Mar 12 | F | 3,125 | $60.13 | $187,906 | 17,086 | No | Form 4 |
| Lenkowsky AdamEVP, Chief Commercial Officer | Mar 10 | Mar 12 | M | 8,241 | $0.00 | $0 | 25,327 | No | Form 4 |
| Lenkowsky AdamEVP, Chief Commercial Officer | Mar 10 | Mar 12 | J | 4,046 | $0.00 | $0 | 21,281 | No | Form 4 |
| Lenkowsky AdamEVP, Chief Commercial Officer | Mar 10 | Mar 12 | F | 2,146 | $60.13 | $129,039 | 19,135 | No | Form 4 |
| Lenkowsky AdamEVP, Chief Commercial Officer | Mar 10 | Mar 12 | M · derivative | 1,828 | $0.00 | $0 | not reported | No | Form 4 |
| Lenkowsky AdamEVP, Chief Commercial Officer | Mar 10 | Mar 12 | M · derivative | 2,000 | $0.00 | $0 | 2,001 | No | Form 4 |
| Lenkowsky AdamEVP, Chief Commercial Officer | Mar 10 | Mar 12 | M · derivative | 12,002 | $0.00 | $0 | not reported | No | Form 4 |
| Lenkowsky AdamEVP, Chief Commercial Officer | Mar 10 | Mar 12 | M · derivative | 8,241 | $0.00 | $0 | not reported | No | Form 4 |
| Lenkowsky AdamEVP, Chief Commercial Officer | Mar 10 | Mar 12 | A · derivative | 32,653 | $0.00 | $0 | 32,653 | No | Form 4 |
| Lenkowsky AdamEVP, Chief Commercial Officer | Mar 10 | Mar 12 | A · derivative | 48,980 | $0.00 | $0 | 48,980 | No | Form 4 |
| Gallman CariEVP, General Counsel | Mar 10 | Mar 12 | M | 912 | $0.00 | $0 | 11,978 | No | Form 4 |
| Gallman CariEVP, General Counsel | Mar 10 | Mar 12 | J | 102 | $0.00 | $0 | 11,876 | No | Form 4 |
| Gallman CariEVP, General Counsel | Mar 10 | Mar 12 | F | 415 | $60.13 | $24,954 | 11,461 | No | Form 4 |
| Gallman CariEVP, General Counsel | Mar 10 | Mar 12 | M | 867 | $0.00 | $0 | 12,328 | No | Form 4 |
| Gallman CariEVP, General Counsel | Mar 10 | Mar 12 | J | 94 | $0.00 | $0 | 12,234 | No | Form 4 |
| Gallman CariEVP, General Counsel | Mar 10 | Mar 12 | F | 396 | $60.13 | $23,811 | 11,838 | No | Form 4 |
| Gallman CariEVP, General Counsel | Mar 10 | Mar 12 | M | 5,201 | $0.00 | $0 | 17,039 | No | Form 4 |
| Gallman CariEVP, General Counsel | Mar 10 | Mar 12 | J | 2,554 | $0.00 | $0 | 14,485 | No | Form 4 |
| Gallman CariEVP, General Counsel | Mar 10 | Mar 12 | F | 1,354 | $60.13 | $81,416 | 13,131 | No | Form 4 |
| Gallman CariEVP, General Counsel | Mar 10 | Mar 12 | M · derivative | 912 | $0.00 | $0 | not reported | No | Form 4 |
| Gallman CariEVP, General Counsel | Mar 10 | Mar 12 | M · derivative | 867 | $0.00 | $0 | 867 | No | Form 4 |
| Gallman CariEVP, General Counsel | Mar 10 | Mar 12 | M · derivative | 5,201 | $0.00 | $0 | not reported | No | Form 4 |
| Gallman CariEVP, General Counsel | Mar 10 | Mar 12 | A · derivative | 26,122 | $0.00 | $0 | 26,122 | No | Form 4 |
| Gallman CariEVP, General Counsel | Mar 10 | Mar 12 | A · derivative | 39,184 | $0.00 | $0 | 39,184 | No | Form 4 |
| Poole Ahn AmandaEVP, Chief People Officer | Mar 10 | Mar 12 | M | 811 | $0.00 | $0 | 6,007 | No | Form 4 |
| Poole Ahn AmandaEVP, Chief People Officer | Mar 10 | Mar 12 | J | 91 | $0.00 | $0 | 5,916 | No | Form 4 |
| Poole Ahn AmandaEVP, Chief People Officer | Mar 10 | Mar 12 | F | 369 | $60.13 | $22,188 | 5,547 | No | Form 4 |
| Poole Ahn AmandaEVP, Chief People Officer | Mar 10 | Mar 12 | M | 803 | $0.00 | $0 | 6,350 | No | Form 4 |
| Poole Ahn AmandaEVP, Chief People Officer | Mar 10 | Mar 12 | J | 87 | $0.00 | $0 | 6,263 | No | Form 4 |
| Poole Ahn AmandaEVP, Chief People Officer | Mar 10 | Mar 12 | F | 367 | $60.13 | $22,068 | 5,896 | No | Form 4 |
| Poole Ahn AmandaEVP, Chief People Officer | Mar 10 | Mar 12 | M | 4,822 | $0.00 | $0 | 10,718 | No | Form 4 |
| Poole Ahn AmandaEVP, Chief People Officer | Mar 10 | Mar 12 | J | 2,368 | $0.00 | $0 | 8,350 | No | Form 4 |
| Poole Ahn AmandaEVP, Chief People Officer | Mar 10 | Mar 12 | F | 1,256 | $60.13 | $75,523 | 7,094 | No | Form 4 |
| Poole Ahn AmandaEVP, Chief People Officer | Mar 10 | Mar 12 | M · derivative | 811 | $0.00 | $0 | not reported | No | Form 4 |
| Poole Ahn AmandaEVP, Chief People Officer | Mar 10 | Mar 12 | M · derivative | 803 | $0.00 | $0 | 805 | No | Form 4 |
| Poole Ahn AmandaEVP, Chief People Officer | Mar 10 | Mar 12 | M · derivative | 4,822 | $0.00 | $0 | not reported | No | Form 4 |
| Poole Ahn AmandaEVP, Chief People Officer | Mar 10 | Mar 12 | A · derivative | 15,347 | $0.00 | $0 | 15,347 | No | Form 4 |
| Poole Ahn AmandaEVP, Chief People Officer | Mar 10 | Mar 12 | A · derivative | 23,020 | $0.00 | $0 | 23,020 | No | Form 4 |
| Hoch LynellePresident, Cell Therapy Org. | Mar 10 | Mar 12 | M | 838 | $0.00 | $0 | 5,549 | No | Form 4 |
| Hoch LynellePresident, Cell Therapy Org. | Mar 10 | Mar 12 | J | 94 | $0.00 | $0 | 5,455 | No | Form 4 |
| Hoch LynellePresident, Cell Therapy Org. | Mar 10 | Mar 12 | F | 212 | $60.13 | $12,748 | 5,243 | No | Form 4 |
| Hoch LynellePresident, Cell Therapy Org. | Mar 10 | Mar 12 | M | 1,050 | $0.00 | $0 | 6,293 | No | Form 4 |
| Hoch LynellePresident, Cell Therapy Org. | Mar 10 | Mar 12 | J | 113 | $0.00 | $0 | 6,180 | No | Form 4 |
| Hoch LynellePresident, Cell Therapy Org. | Mar 10 | Mar 12 | F | 267 | $60.13 | $16,055 | 5,913 | No | Form 4 |
| Hoch LynellePresident, Cell Therapy Org. | Mar 10 | Mar 12 | M | 6,304 | $0.00 | $0 | 12,217 | No | Form 4 |
| Hoch LynellePresident, Cell Therapy Org. | Mar 10 | Mar 12 | J | 3,095 | $0.00 | $0 | 9,122 | No | Form 4 |
| Hoch LynellePresident, Cell Therapy Org. | Mar 10 | Mar 12 | F | 912 | $60.13 | $54,839 | 8,210 | No | Form 4 |
| Hoch LynellePresident, Cell Therapy Org. | Mar 10 | Mar 12 | M · derivative | 838 | $0.00 | $0 | not reported | No | Form 4 |
| Hoch LynellePresident, Cell Therapy Org. | Mar 10 | Mar 12 | M · derivative | 1,050 | $0.00 | $0 | 1,052 | No | Form 4 |
| Hoch LynellePresident, Cell Therapy Org. | Mar 10 | Mar 12 | M · derivative | 6,304 | $0.00 | $0 | not reported | No | Form 4 |
| Hoch LynellePresident, Cell Therapy Org. | Mar 10 | Mar 12 | A · derivative | 6,531 | $0.00 | $0 | 6,531 | No | Form 4 |
| Hoch LynellePresident, Cell Therapy Org. | Mar 10 | Mar 12 | A · derivative | 9,796 | $0.00 | $0 | 9,796 | No | Form 4 |
| Holzer Phil MSVP and Controller | Mar 10 | Mar 12 | M | 811 | $0.00 | $0 | 15,778 | No | Form 4 |
| Holzer Phil MSVP and Controller | Mar 10 | Mar 12 | J | 91 | $0.00 | $0 | 15,687 | No | Form 4 |
| Holzer Phil MSVP and Controller | Mar 10 | Mar 12 | F | 261 | $60.13 | $15,694 | 15,426 | No | Form 4 |
| Holzer Phil MSVP and Controller | Mar 10 | Mar 12 | M | 768 | $0.00 | $0 | 16,194 | No | Form 4 |
| Holzer Phil MSVP and Controller | Mar 10 | Mar 12 | J | 83 | $0.00 | $0 | 16,111 | No | Form 4 |
| Holzer Phil MSVP and Controller | Mar 10 | Mar 12 | F | 248 | $60.13 | $14,912 | 15,863 | No | Form 4 |
| Holzer Phil MSVP and Controller | Mar 10 | Mar 12 | M | 4,612 | $0.00 | $0 | 20,475 | No | Form 4 |
| Holzer Phil MSVP and Controller | Mar 10 | Mar 12 | J | 2,264 | $0.00 | $0 | 18,211 | No | Form 4 |
| Holzer Phil MSVP and Controller | Mar 10 | Mar 12 | F | 849 | $60.13 | $51,050 | 17,362 | No | Form 4 |
| Holzer Phil MSVP and Controller | Mar 10 | Mar 12 | M · derivative | 811 | $0.00 | $0 | not reported | No | Form 4 |
| Holzer Phil MSVP and Controller | Mar 10 | Mar 12 | M · derivative | 768 | $0.00 | $0 | 771 | No | Form 4 |
| Holzer Phil MSVP and Controller | Mar 10 | Mar 12 | M · derivative | 4,612 | $0.00 | $0 | not reported | No | Form 4 |
| Holzer Phil MSVP and Controller | Mar 10 | Mar 12 | A · derivative | 5,031 | $0.00 | $0 | 5,031 | No | Form 4 |
| Holzer Phil MSVP and Controller | Mar 10 | Mar 12 | A · derivative | 7,547 | $0.00 | $0 | 7,547 | No | Form 4 |
| Short Bartie WendyEVP, Corporate Affairs | Mar 10 | Mar 12 | M | 639 | $0.00 | $0 | 6,308 | No | Form 4 |
| Short Bartie WendyEVP, Corporate Affairs | Mar 10 | Mar 12 | J | 72 | $0.00 | $0 | 6,236 | No | Form 4 |
| Short Bartie WendyEVP, Corporate Affairs | Mar 10 | Mar 12 | F | 205 | $60.13 | $12,327 | 6,031 | No | Form 4 |
| Short Bartie WendyEVP, Corporate Affairs | Mar 10 | Mar 12 | M | 749 | $0.00 | $0 | 6,780 | No | Form 4 |
| Short Bartie WendyEVP, Corporate Affairs | Mar 10 | Mar 12 | J | 81 | $0.00 | $0 | 6,699 | No | Form 4 |
| Short Bartie WendyEVP, Corporate Affairs | Mar 10 | Mar 12 | F | 242 | $60.13 | $14,551 | 6,457 | No | Form 4 |
| Short Bartie WendyEVP, Corporate Affairs | Mar 10 | Mar 12 | M | 4,495 | $0.00 | $0 | 10,952 | No | Form 4 |
| Short Bartie WendyEVP, Corporate Affairs | Mar 10 | Mar 12 | J | 2,207 | $0.00 | $0 | 8,745 | No | Form 4 |
| Short Bartie WendyEVP, Corporate Affairs | Mar 10 | Mar 12 | F | 828 | $60.13 | $49,788 | 7,917 | No | Form 4 |
| Short Bartie WendyEVP, Corporate Affairs | Mar 10 | Mar 12 | M · derivative | 639 | $0.00 | $0 | not reported | No | Form 4 |
| Short Bartie WendyEVP, Corporate Affairs | Mar 10 | Mar 12 | M · derivative | 749 | $0.00 | $0 | 750 | No | Form 4 |
| Short Bartie WendyEVP, Corporate Affairs | Mar 10 | Mar 12 | M · derivative | 4,495 | $0.00 | $0 | not reported | No | Form 4 |
| Short Bartie WendyEVP, Corporate Affairs | Mar 10 | Mar 12 | A · derivative | 6,531 | $0.00 | $0 | 6,531 | No | Form 4 |
| Short Bartie WendyEVP, Corporate Affairs | Mar 10 | Mar 12 | A · derivative | 9,796 | $0.00 | $0 | 9,796 | No | Form 4 |
| Shibutani Hiroshi ChrisEVP, Chief Strategy Officer | Mar 10 | Mar 12 | A · derivative | 7,837 | $0.00 | $0 | 7,837 | No | Form 4 |
| Shibutani Hiroshi ChrisEVP, Chief Strategy Officer | Mar 10 | Mar 12 | A · derivative | 11,755 | $0.00 | $0 | 11,755 | No | Form 4 |
| Massacesi CristianEVP,Chief Med Offr,Head of Dev | Mar 10 | Mar 12 | A · derivative | 26,122 | $0.00 | $0 | 26,122 | No | Form 4 |
| Massacesi CristianEVP,Chief Med Offr,Head of Dev | Mar 10 | Mar 12 | A · derivative | 39,184 | $0.00 | $0 | 39,184 | No | Form 4 |
| Hickey BenjaminPresident, RayzeBio Org. | Feb 27 | Mar 3 | M | 3,286 | $0.00 | $0 | 18,344 | No | Form 4 |
| Hickey BenjaminPresident, RayzeBio Org. | Feb 27 | Mar 3 | F | 1,672 | $62.37 | $104,283 | 16,672 | No | Form 4 |
| Hickey BenjaminPresident, RayzeBio Org. | Feb 27 | Mar 3 | M · derivative | 3,286 | $0.00 | $0 | 3,286 | No | Form 4 |
| Yale Phyllis R | Feb 1 | Feb 3 | A · derivative | 3,996.37 | $55.05 | $220,000 | 43,326.7 | No | Form 4 |
| Arduini Peter J | Feb 1 | Feb 3 | A · derivative | 3,996.37 | $55.05 | $220,000 | 70,858.08 | No | Form 4 |
| Rice Derica W | Feb 1 | Feb 3 | A · derivative | 3,996.37 | $55.05 | $220,000 | 39,324.81 | No | Form 4 |
| Price Paula A | Feb 1 | Feb 3 | A · derivative | 3,996.37 | $55.05 | $220,000 | 25,498.16 | No | Form 4 |
| McMullen Michael R. | Feb 1 | Feb 3 | A · derivative | 3,996.37 | $55.05 | $220,000 | 14,979.69 | No | Form 4 |
| Haller Julia A | Feb 1 | Feb 3 | A · derivative | 3,996.37 | $55.05 | $220,000 | 37,903.15 | No | Form 4 |
| Samuels Theodore R. II | Feb 1 | Feb 3 | A · derivative | 3,996.37 | $55.05 | $220,000 | 67,882.5 | No | Form 4 |
| Vousden Karen H | Feb 1 | Feb 3 | A · derivative | 3,996.37 | $55.05 | $220,000 | 41,069.32 | No | Form 4 |
| Hickey BenjaminPresident, RayzeBio Org. | Feb 1 | Feb 3 | M | 10,079 | $0.00 | $0 | 18,868 | No | Form 4 |
| Hickey BenjaminPresident, RayzeBio Org. | Feb 1 | Feb 3 | F | 3,810 | $55.05 | $209,741 | 15,058 | No | Form 4 |
| Hickey BenjaminPresident, RayzeBio Org. | Feb 1 | Feb 3 | M · derivative | 10,079 | $0.00 | $0 | 10,079 | No | Form 4 |
| Hidalgo Medina Manuel | Feb 1 | Feb 3 | A · derivative | 3,996.37 | $55.05 | $220,000 | 22,763.94 | No | Form 4 |
| Meyers Gregory ScottEVP, Chief Digital & Tech Off. | Feb 1 | Feb 3 | M | 2,543 | $0.00 | $0 | 22,261 | No | Form 4 |
| Meyers Gregory ScottEVP, Chief Digital & Tech Off. | Feb 1 | Feb 3 | F | 833 | $55.05 | $45,857 | 21,428 | No | Form 4 |
| Meyers Gregory ScottEVP, Chief Digital & Tech Off. | Feb 1 | Feb 3 | M · derivative | 2,543 | $0.00 | $0 | not reported | No | Form 4 |
| Bhatt Deepak | Feb 1 | Feb 3 | A · derivative | 3,996.37 | $55.05 | $220,000 | 19,241.82 | No | Form 4 |
| Yale Phyllis R | Dec 31, 2025 | Jan 5 | A · derivative | 648.87 | $0.00 | $0 | 38,891.93 | No | Form 4 |
| Arduini Peter J | Dec 31, 2025 | Jan 5 | A · derivative | 625.7 | $0.00 | $0 | 66,116.45 | No | Form 4 |
| Rice Derica W | Dec 31, 2025 | Jan 5 | A · derivative | 695.22 | $0.00 | $0 | 34,934.65 | No | Form 4 |
| McMullen Michael R. | Dec 31, 2025 | Jan 5 | A · derivative | 648.87 | $0.00 | $0 | 10,860.9 | No | Form 4 |
| Samuels Theodore R. II | Dec 31, 2025 | Jan 5 | A · derivative | 926.96 | $0.00 | $0 | 63,174.03 | No | Form 4 |
| Lenkowsky AdamEVP, Chief Commercial Officer | Nov 3, 2025 | Nov 4, 2025 | A · derivative | 22,568 | $0.00 | $0 | 22,568 | No | Form 4 |
| Boerner Christopher S.Chief Executive Officer | Nov 1, 2025 | Nov 4, 2025 | M | 2,964 | $0.00 | $0 | 2,964 | No | Form 4 |
| Boerner Christopher S.Chief Executive Officer | Nov 1, 2025 | Nov 4, 2025 | J | 544 | $0.00 | $0 | 2,420 | No | Form 4 |
| Boerner Christopher S.Chief Executive Officer | Nov 1, 2025 | Nov 4, 2025 | F | 1,238 | $46.07 | $57,035 | 1,182 | No | Form 4 |
| Boerner Christopher S.Chief Executive Officer | Nov 1, 2025 | Nov 4, 2025 | M · derivative | 2,964 | $0.00 | $0 | 5,930 | No | Form 4 |
| Meyers Gregory ScottEVP, Chief Digital & Tech Off. | Nov 1, 2025 | Nov 4, 2025 | M | 6,281 | $0.00 | $0 | 22,383 | No | Form 4 |
| Meyers Gregory ScottEVP, Chief Digital & Tech Off. | Nov 1, 2025 | Nov 4, 2025 | F | 2,665 | $46.07 | $122,777 | 19,718 | No | Form 4 |
| Meyers Gregory ScottEVP, Chief Digital & Tech Off. | Nov 1, 2025 | Nov 4, 2025 | M · derivative | 6,281 | $0.00 | $0 | 12,562 | No | Form 4 |
| Shanahan KarinEVP, Chief Supply Chain & Ops | Nov 1, 2025 | Nov 4, 2025 | M | 6,281 | $0.00 | $0 | 20,078 | No | Form 4 |
| Shanahan KarinEVP, Chief Supply Chain & Ops | Nov 1, 2025 | Nov 4, 2025 | F | 3,213 | $46.07 | $148,023 | 16,865 | No | Form 4 |
| Shanahan KarinEVP, Chief Supply Chain & Ops | Nov 1, 2025 | Nov 4, 2025 | M · derivative | 6,281 | $0.00 | $0 | 12,562 | No | Form 4 |
| Gallman CariEVP, General Counsel | Oct 2, 2025 | Oct 6, 2025 | M | 4,558 | $0.00 | $0 | 13,398 | No | Form 4 |
| Gallman CariEVP, General Counsel | Oct 2, 2025 | Oct 6, 2025 | F | 2,332 | $45.73 | $106,642 | 11,066 | No | Form 4 |
| Gallman CariEVP, General Counsel | Oct 2, 2025 | Oct 6, 2025 | M · derivative | 4,558 | $0.00 | $0 | 4,559 | No | Form 4 |
| Yale Phyllis R | Sep 30, 2025 | Oct 2, 2025 | A · derivative | 776.05 | $0.00 | $0 | 37,734.69 | No | Form 4 |
| Arduini Peter J | Sep 30, 2025 | Oct 2, 2025 | A · derivative | 748.34 | $0.00 | $0 | 64,620.16 | No | Form 4 |
| Rice Derica W | Sep 30, 2025 | Oct 2, 2025 | A · derivative | 831.49 | $0.00 | $0 | 33,784.28 | No | Form 4 |
| McMullen Michael R. | Sep 30, 2025 | Oct 2, 2025 | A · derivative | 776.05 | $0.00 | $0 | 10,076.28 | No | Form 4 |
| Samuels Theodore R. II | Sep 30, 2025 | Oct 2, 2025 | A · derivative | 1,108.65 | $0.00 | $0 | 61,419.6 | No | Form 4 |
| Elkins David VEVP, Chief Financial Officer | Sep 2, 2025 | Sep 3, 2025 | S | 56,000 | $47.33 | Sale −$2,650,480 | 167,379 | No | Form 4 |
| Short Bartie WendyEVP, Corporate Affairs | Sep 1, 2025 | Sep 3, 2025 | M | 1,235 | $0.00 | $0 | 6,301 | No | Form 4 |
| Short Bartie WendyEVP, Corporate Affairs | Sep 1, 2025 | Sep 3, 2025 | F | 632 | $47.18 | $29,818 | 5,669 | No | Form 4 |
| Short Bartie WendyEVP, Corporate Affairs | Sep 1, 2025 | Sep 3, 2025 | M · derivative | 1,235 | $0.00 | $0 | 1,236 | No | Form 4 |
| Short Bartie WendyEVP, Corporate Affairs | Aug 2, 2025 | Aug 5, 2025 | M | 738 | $0.00 | $0 | 5,444 | No | Form 4 |
| Short Bartie WendyEVP, Corporate Affairs | Aug 2, 2025 | Aug 5, 2025 | S | 378 | $44.23 | Sale −$16,719 | 5,066 | No | Form 4 |
| Short Bartie WendyEVP, Corporate Affairs | Aug 2, 2025 | Aug 5, 2025 | M · derivative | 738 | $0.00 | $0 | not reported | No | Form 4 |
| Gallman CariEVP, General Counsel | Aug 1, 2025 | Aug 5, 2025 | M | 1,061 | $0.00 | $0 | 9,383 | No | Form 4 |
| Gallman CariEVP, General Counsel | Aug 1, 2025 | Aug 5, 2025 | F | 543 | $44.23 | $24,017 | 8,840 | No | Form 4 |
| Gallman CariEVP, General Counsel | Aug 1, 2025 | Aug 5, 2025 | M · derivative | 1,061 | $0.00 | $0 | 1,061 | No | Form 4 |
| Massacesi CristianEVP,Chief Med Offr,Head of Dev | Aug 1, 2025 | Aug 5, 2025 | A · derivative | 204,691 | $0.00 | $0 | 204,691 | No | Form 4 |
| Shibutani Hiroshi ChrisEVP, Chief Strategy Officer | Jul 1, 2025 | Jul 2, 2025 | A · derivative | 12,810 | $0.00 | $0 | 12,810 | No | Form 4 |
| Yale Phyllis R | Jun 30, 2025 | Jul 1, 2025 | A · derivative | 756.1 | $0.00 | $0 | 36,447.72 | No | Form 4 |
| Samuels Theodore R. II | Jun 30, 2025 | Jul 1, 2025 | A · derivative | 1,080.15 | $0.00 | $0 | 59,477.23 | No | Form 4 |
| Rice Derica W | Jun 30, 2025 | Jul 1, 2025 | A · derivative | 810.11 | $0.00 | $0 | 32,497.26 | No | Form 4 |
| McMullen Michael R. | Jun 30, 2025 | Jul 1, 2025 | A · derivative | 728.36 | $0.00 | $0 | 9,171.66 | No | Form 4 |
| Arduini Peter J | Jun 30, 2025 | Jul 1, 2025 | A · derivative | 729.1 | $0.00 | $0 | 62,988.87 | No | Form 4 |
| Boerner Christopher S.Chief Executive Officer | Jun 13, 2025 | Jun 16, 2025 | G | 62,719 | $0.00 | $0 | not reported | No | Form 4 |
| Boerner Christopher S.Chief Executive Officer | Jun 13, 2025 | Jun 16, 2025 | G | 62,719 | $0.00 | $0 | 125,439 | No | Form 4 |
| Boerner Christopher S.Chief Executive Officer | Jun 3, 2025 | Jun 4, 2025 | G | 62,720 | $0.00 | $0 | 62,719 | No | Form 4 |
| Boerner Christopher S.Chief Executive Officer | Jun 3, 2025 | Jun 4, 2025 | G | 62,720 | $0.00 | $0 | 62,720 | No | Form 4 |
| Short Bartie WendyEVP, Corporate Affairs | Jun 3, 2025 | Jun 4, 2025 | M | 8,040 | $0.00 | $0 | 8,040 | No | Form 4 |
| Short Bartie WendyEVP, Corporate Affairs | Jun 3, 2025 | Jun 4, 2025 | F | 3,334 | $48.09 | $160,332 | 4,706 | No | Form 4 |
| Short Bartie WendyEVP, Corporate Affairs | Jun 3, 2025 | Jun 4, 2025 | M · derivative | 8,040 | $0.00 | $0 | 16,080 | No | Form 4 |
| Hickey BenjaminPresident, RayzeBio Org. | May 9, 2025 | May 13, 2025 | S | 97.39 | $38.01 | Sale −$3,702 | not reported | No | Form 4 |
| Lenkowsky AdamEVP, Chief Commercial Officer | May 1, 2025 | May 5, 2025 | J · derivative | 1,373 | $0.00 | $0 | 2,748 | No | Form 4 |
| Hirawat SamitEVP,Chief Med.Offr.,Drug Dev. | Apr 25, 2025 | Apr 29, 2025 | P | 4,250 | $47.58 | Purchase +$202,215 | 83,513.49 | No | Form 4 |
| Shanahan KarinEVP, Glob. Prod. Dev. & Supply | Apr 1, 2025 | Apr 3, 2025 | M | 3,306 | $0.00 | $0 | 15,489 | No | Form 4 |
| Shanahan KarinEVP, Glob. Prod. Dev. & Supply | Apr 1, 2025 | Apr 3, 2025 | F | 1,692 | $59.55 | $100,759 | 13,797 | No | Form 4 |
| Shanahan KarinEVP, Glob. Prod. Dev. & Supply | Apr 1, 2025 | Apr 3, 2025 | M · derivative | 3,306 | $0.00 | $0 | 3,307 | No | Form 4 |
| Arduini Peter J | Mar 31, 2025 | Apr 1, 2025 | A · derivative | 553.37 | $60.99 | $33,750 | 61,491.29 | No | Form 4 |
| McMullen Michael R. | Mar 31, 2025 | Apr 1, 2025 | A · derivative | 512.38 | $60.99 | $31,250 | 8,339.08 | No | Form 4 |
| Rice Derica W | Mar 31, 2025 | Apr 1, 2025 | A · derivative | 614.86 | $60.99 | $37,500 | 31,296.03 | No | Form 4 |
| Samuels Theodore R. II | Mar 31, 2025 | Apr 1, 2025 | A · derivative | 819.81 | $60.99 | $50,000 | 57,676.27 | No | Form 4 |
| Yale Phyllis R | Mar 31, 2025 | Apr 1, 2025 | A · derivative | 573.87 | $60.99 | $35,000 | 35,251.07 | No | Form 4 |
| Boerner Christopher S.Chief Executive Officer | Mar 10, 2025 | Mar 12, 2025 | M | 6,985 | $0.00 | $0 | 111,611 | No | Form 4 |
| Boerner Christopher S.Chief Executive Officer | Mar 10, 2025 | Mar 12, 2025 | J | 482 | $0.00 | $0 | 111,129 | No | Form 4 |
| Boerner Christopher S.Chief Executive Officer | Mar 10, 2025 | Mar 12, 2025 | F | 3,327 | $63.11 | $209,967 | 107,802 | No | Form 4 |
| Boerner Christopher S.Chief Executive Officer | Mar 10, 2025 | Mar 12, 2025 | M | 6,616 | $0.00 | $0 | 114,418 | No | Form 4 |
| Boerner Christopher S.Chief Executive Officer | Mar 10, 2025 | Mar 12, 2025 | J | 1,154 | $0.00 | $0 | 113,264 | No | Form 4 |
| Boerner Christopher S.Chief Executive Officer | Mar 10, 2025 | Mar 12, 2025 | F | 2,794 | $63.11 | $176,329 | 110,470 | No | Form 4 |
| Boerner Christopher S.Chief Executive Officer | Mar 10, 2025 | Mar 12, 2025 | M | 6,733 | $0.00 | $0 | 117,203 | No | Form 4 |
| Boerner Christopher S.Chief Executive Officer | Mar 10, 2025 | Mar 12, 2025 | J | 1,147 | $0.00 | $0 | 116,056 | No | Form 4 |
| Boerner Christopher S.Chief Executive Officer | Mar 10, 2025 | Mar 12, 2025 | F | 2,858 | $63.11 | $180,368 | 113,198 | No | Form 4 |
| Boerner Christopher S.Chief Executive Officer | Mar 10, 2025 | Mar 12, 2025 | M | 39,700 | $0.00 | $0 | 152,898 | No | Form 4 |
| Boerner Christopher S.Chief Executive Officer | Mar 10, 2025 | Mar 12, 2025 | J | 14,641 | $0.00 | $0 | 138,257 | No | Form 4 |
| Boerner Christopher S.Chief Executive Officer | Mar 10, 2025 | Mar 12, 2025 | F | 12,818 | $63.11 | $808,944 | 125,439 | No | Form 4 |
| Boerner Christopher S.Chief Executive Officer | Mar 10, 2025 | Mar 12, 2025 | M · derivative | 6,985 | $0.00 | $0 | not reported | No | Form 4 |
| Boerner Christopher S.Chief Executive Officer | Mar 10, 2025 | Mar 12, 2025 | M · derivative | 6,616 | $0.00 | $0 | 6,618 | No | Form 4 |
| Boerner Christopher S.Chief Executive Officer | Mar 10, 2025 | Mar 12, 2025 | M · derivative | 6,733 | $0.00 | $0 | 13,466 | No | Form 4 |
| Boerner Christopher S.Chief Executive Officer | Mar 10, 2025 | Mar 12, 2025 | A · derivative | 97,071 | $0.00 | $0 | 97,071 | No | Form 4 |
| Boerner Christopher S.Chief Executive Officer | Mar 10, 2025 | Mar 12, 2025 | M · derivative | 39,700 | $0.00 | $0 | not reported | No | Form 4 |
| Boerner Christopher S.Chief Executive Officer | Mar 10, 2025 | Mar 12, 2025 | A · derivative | 145,607 | $0.00 | $0 | 145,607 | No | Form 4 |
| Elkins David VEVP, Chief Financial Officer | Mar 10, 2025 | Mar 12, 2025 | M | 8,045 | $0.00 | $0 | 203,013 | No | Form 4 |
| Elkins David VEVP, Chief Financial Officer | Mar 10, 2025 | Mar 12, 2025 | J | 555 | $0.00 | $0 | 202,458 | No | Form 4 |
| Elkins David VEVP, Chief Financial Officer | Mar 10, 2025 | Mar 12, 2025 | F | 3,178 | $63.11 | $200,564 | 199,280 | No | Form 4 |
| Elkins David VEVP, Chief Financial Officer | Mar 10, 2025 | Mar 12, 2025 | M | 7,652 | $0.00 | $0 | 206,932 | No | Form 4 |
| Elkins David VEVP, Chief Financial Officer | Mar 10, 2025 | Mar 12, 2025 | J | 1,335 | $0.00 | $0 | 205,597 | No | Form 4 |
| Elkins David VEVP, Chief Financial Officer | Mar 10, 2025 | Mar 12, 2025 | F | 2,680 | $63.11 | $169,135 | 202,917 | No | Form 4 |
| Elkins David VEVP, Chief Financial Officer | Mar 10, 2025 | Mar 12, 2025 | M | 7,904 | $0.00 | $0 | 210,821 | No | Form 4 |
| Elkins David VEVP, Chief Financial Officer | Mar 10, 2025 | Mar 12, 2025 | J | 1,347 | $0.00 | $0 | 209,474 | No | Form 4 |
| Elkins David VEVP, Chief Financial Officer | Mar 10, 2025 | Mar 12, 2025 | F | 2,782 | $63.11 | $175,572 | 206,692 | No | Form 4 |
| Elkins David VEVP, Chief Financial Officer | Mar 10, 2025 | Mar 12, 2025 | M | 45,916 | $0.00 | $0 | 252,608 | No | Form 4 |
| Elkins David VEVP, Chief Financial Officer | Mar 10, 2025 | Mar 12, 2025 | J | 16,934 | $0.00 | $0 | 235,674 | No | Form 4 |
| Elkins David VEVP, Chief Financial Officer | Mar 10, 2025 | Mar 12, 2025 | F | 12,295 | $63.11 | $775,937 | 223,379 | No | Form 4 |
| Elkins David VEVP, Chief Financial Officer | Mar 10, 2025 | Mar 12, 2025 | M · derivative | 8,045 | $0.00 | $0 | not reported | No | Form 4 |
| Elkins David VEVP, Chief Financial Officer | Mar 10, 2025 | Mar 12, 2025 | M · derivative | 7,652 | $0.00 | $0 | 7,654 | No | Form 4 |
| Elkins David VEVP, Chief Financial Officer | Mar 10, 2025 | Mar 12, 2025 | M · derivative | 7,904 | $0.00 | $0 | 15,808 | No | Form 4 |
| Elkins David VEVP, Chief Financial Officer | Mar 10, 2025 | Mar 12, 2025 | A · derivative | 36,151 | $0.00 | $0 | 36,151 | No | Form 4 |
| Elkins David VEVP, Chief Financial Officer | Mar 10, 2025 | Mar 12, 2025 | M · derivative | 45,916 | $0.00 | $0 | not reported | No | Form 4 |
| Elkins David VEVP, Chief Financial Officer | Mar 10, 2025 | Mar 12, 2025 | A · derivative | 54,226 | $0.00 | $0 | 54,226 | No | Form 4 |
| Gallman CariEVP, Corporate Affairs | Mar 10, 2025 | Mar 12, 2025 | M | 349 | $0.00 | $0 | 5,368 | No | Form 4 |
| Gallman CariEVP, Corporate Affairs | Mar 10, 2025 | Mar 12, 2025 | J | 24 | $0.00 | $0 | 5,344 | No | Form 4 |
| Gallman CariEVP, Corporate Affairs | Mar 10, 2025 | Mar 12, 2025 | F | 118 | $63.11 | $7,447 | 5,226 | No | Form 4 |
| Gallman CariEVP, Corporate Affairs | Mar 10, 2025 | Mar 12, 2025 | M | 910 | $0.00 | $0 | 6,136 | No | Form 4 |
| Gallman CariEVP, Corporate Affairs | Mar 10, 2025 | Mar 12, 2025 | J | 159 | $0.00 | $0 | 5,977 | No | Form 4 |
| Gallman CariEVP, Corporate Affairs | Mar 10, 2025 | Mar 12, 2025 | F | 272 | $63.11 | $17,166 | 5,705 | No | Form 4 |
| Gallman CariEVP, Corporate Affairs | Mar 10, 2025 | Mar 12, 2025 | M | 867 | $0.00 | $0 | 6,572 | No | Form 4 |
| Gallman CariEVP, Corporate Affairs | Mar 10, 2025 | Mar 12, 2025 | J | 148 | $0.00 | $0 | 6,424 | No | Form 4 |
| Gallman CariEVP, Corporate Affairs | Mar 10, 2025 | Mar 12, 2025 | F | 260 | $63.11 | $16,409 | 6,164 | No | Form 4 |
| Gallman CariEVP, Corporate Affairs | Mar 10, 2025 | Mar 12, 2025 | M | 5,462 | $0.00 | $0 | 11,626 | No | Form 4 |
| Gallman CariEVP, Corporate Affairs | Mar 10, 2025 | Mar 12, 2025 | J | 2,014 | $0.00 | $0 | 9,612 | No | Form 4 |
| Gallman CariEVP, Corporate Affairs | Mar 10, 2025 | Mar 12, 2025 | F | 1,290 | $63.11 | $81,412 | 8,322 | No | Form 4 |
| Gallman CariEVP, Corporate Affairs | Mar 10, 2025 | Mar 12, 2025 | M · derivative | 349 | $0.00 | $0 | not reported | No | Form 4 |
| Gallman CariEVP, Corporate Affairs | Mar 10, 2025 | Mar 12, 2025 | M · derivative | 910 | $0.00 | $0 | 912 | No | Form 4 |
| Gallman CariEVP, Corporate Affairs | Mar 10, 2025 | Mar 12, 2025 | M · derivative | 867 | $0.00 | $0 | 1,734 | No | Form 4 |
| Gallman CariEVP, Corporate Affairs | Mar 10, 2025 | Mar 12, 2025 | A · derivative | 13,389 | $0.00 | $0 | 13,389 | No | Form 4 |
| Gallman CariEVP, Corporate Affairs | Mar 10, 2025 | Mar 12, 2025 | M · derivative | 5,462 | $0.00 | $0 | not reported | No | Form 4 |
| Gallman CariEVP, Corporate Affairs | Mar 10, 2025 | Mar 12, 2025 | A · derivative | 20,084 | $0.00 | $0 | 20,084 | No | Form 4 |
| Hickey BenjaminPresident, RayzeBio Org. | Mar 10, 2025 | Mar 12, 2025 | A · derivative | 13,389 | $0.00 | $0 | 13,389 | No | Form 4 |
| Hickey BenjaminPresident, RayzeBio Org. | Mar 10, 2025 | Mar 12, 2025 | A · derivative | 20,084 | $0.00 | $0 | 20,084 | No | Form 4 |
| Hirawat SamitEVP,Chief Med.Offr.,Drug Dev. | Mar 10, 2025 | Mar 12, 2025 | M | 4,886 | $0.00 | $0 | 68,818.49 | No | Form 4 |
| Hirawat SamitEVP,Chief Med.Offr.,Drug Dev. | Mar 10, 2025 | Mar 12, 2025 | J | 337 | $0.00 | $0 | 68,481.49 | No | Form 4 |
| Hirawat SamitEVP,Chief Med.Offr.,Drug Dev. | Mar 10, 2025 | Mar 12, 2025 | F | 2,327 | $63.11 | $146,857 | 66,154.49 | No | Form 4 |
| Hirawat SamitEVP,Chief Med.Offr.,Drug Dev. | Mar 10, 2025 | Mar 12, 2025 | M | 4,765 | $0.00 | $0 | 70,919.49 | No | Form 4 |
| Hirawat SamitEVP,Chief Med.Offr.,Drug Dev. | Mar 10, 2025 | Mar 12, 2025 | J | 831 | $0.00 | $0 | 70,088.49 | No | Form 4 |
| Hirawat SamitEVP,Chief Med.Offr.,Drug Dev. | Mar 10, 2025 | Mar 12, 2025 | F | 2,013 | $63.11 | $127,040 | 68,075.49 | No | Form 4 |
| Hirawat SamitEVP,Chief Med.Offr.,Drug Dev. | Mar 10, 2025 | Mar 12, 2025 | M | 5,854 | $0.00 | $0 | 73,929.49 | No | Form 4 |
| Hirawat SamitEVP,Chief Med.Offr.,Drug Dev. | Mar 10, 2025 | Mar 12, 2025 | J | 998 | $0.00 | $0 | 72,931.49 | No | Form 4 |
| Hirawat SamitEVP,Chief Med.Offr.,Drug Dev. | Mar 10, 2025 | Mar 12, 2025 | F | 2,484 | $63.11 | $156,765 | 70,447.49 | No | Form 4 |
| Hirawat SamitEVP,Chief Med.Offr.,Drug Dev. | Mar 10, 2025 | Mar 12, 2025 | M | 28,593 | $0.00 | $0 | 99,040.49 | No | Form 4 |
| Hirawat SamitEVP,Chief Med.Offr.,Drug Dev. | Mar 10, 2025 | Mar 12, 2025 | J | 10,545 | $0.00 | $0 | 88,495.49 | No | Form 4 |
| Hirawat SamitEVP,Chief Med.Offr.,Drug Dev. | Mar 10, 2025 | Mar 12, 2025 | F | 9,232 | $63.11 | $582,632 | 79,263.49 | No | Form 4 |
| Hirawat SamitEVP,Chief Med.Offr.,Drug Dev. | Mar 10, 2025 | Mar 12, 2025 | M · derivative | 4,886 | $0.00 | $0 | not reported | No | Form 4 |
| Hirawat SamitEVP,Chief Med.Offr.,Drug Dev. | Mar 10, 2025 | Mar 12, 2025 | M · derivative | 4,765 | $0.00 | $0 | 4,767 | No | Form 4 |
| Hirawat SamitEVP,Chief Med.Offr.,Drug Dev. | Mar 10, 2025 | Mar 12, 2025 | M · derivative | 5,854 | $0.00 | $0 | 11,711 | No | Form 4 |
| Hirawat SamitEVP,Chief Med.Offr.,Drug Dev. | Mar 10, 2025 | Mar 12, 2025 | A · derivative | 35,146 | $0.00 | $0 | 35,146 | No | Form 4 |
| Hirawat SamitEVP,Chief Med.Offr.,Drug Dev. | Mar 10, 2025 | Mar 12, 2025 | M · derivative | 28,593 | $0.00 | $0 | not reported | No | Form 4 |
| Hirawat SamitEVP,Chief Med.Offr.,Drug Dev. | Mar 10, 2025 | Mar 12, 2025 | A · derivative | 52,720 | $0.00 | $0 | 52,720 | No | Form 4 |
| Holzer Phil MSVP and Controller | Mar 10, 2025 | Mar 12, 2025 | M | 701 | $0.00 | $0 | 12,461 | No | Form 4 |
| Holzer Phil MSVP and Controller | Mar 10, 2025 | Mar 12, 2025 | J | 48 | $0.00 | $0 | 12,413 | No | Form 4 |
| Holzer Phil MSVP and Controller | Mar 10, 2025 | Mar 12, 2025 | F | 237 | $63.11 | $14,957 | 12,176 | No | Form 4 |
| Holzer Phil MSVP and Controller | Mar 10, 2025 | Mar 12, 2025 | M | 810 | $0.00 | $0 | 12,986 | No | Form 4 |
| Holzer Phil MSVP and Controller | Mar 10, 2025 | Mar 12, 2025 | J | 141 | $0.00 | $0 | 12,845 | No | Form 4 |
| Holzer Phil MSVP and Controller | Mar 10, 2025 | Mar 12, 2025 | F | 242 | $63.11 | $15,273 | 12,603 | No | Form 4 |
| Holzer Phil MSVP and Controller | Mar 10, 2025 | Mar 12, 2025 | M | 768 | $0.00 | $0 | 13,371 | No | Form 4 |
| Holzer Phil MSVP and Controller | Mar 10, 2025 | Mar 12, 2025 | J | 131 | $0.00 | $0 | 13,240 | No | Form 4 |
| Holzer Phil MSVP and Controller | Mar 10, 2025 | Mar 12, 2025 | F | 231 | $63.11 | $14,578 | 13,009 | No | Form 4 |
| Holzer Phil MSVP and Controller | Mar 10, 2025 | Mar 12, 2025 | M | 4,861 | $0.00 | $0 | 17,870 | No | Form 4 |
| Holzer Phil MSVP and Controller | Mar 10, 2025 | Mar 12, 2025 | J | 1,793 | $0.00 | $0 | 16,077 | No | Form 4 |
| Holzer Phil MSVP and Controller | Mar 10, 2025 | Mar 12, 2025 | F | 1,110 | $63.11 | $70,052 | 14,967 | No | Form 4 |
| Holzer Phil MSVP and Controller | Mar 10, 2025 | Mar 12, 2025 | M · derivative | 701 | $0.00 | $0 | not reported | No | Form 4 |
| Holzer Phil MSVP and Controller | Mar 10, 2025 | Mar 12, 2025 | M · derivative | 810 | $0.00 | $0 | 811 | No | Form 4 |
| Holzer Phil MSVP and Controller | Mar 10, 2025 | Mar 12, 2025 | M · derivative | 768 | $0.00 | $0 | 1,539 | No | Form 4 |
| Holzer Phil MSVP and Controller | Mar 10, 2025 | Mar 12, 2025 | A · derivative | 4,912 | $0.00 | $0 | 4,912 | No | Form 4 |
| Holzer Phil MSVP and Controller | Mar 10, 2025 | Mar 12, 2025 | M · derivative | 4,861 | $0.00 | $0 | not reported | No | Form 4 |
| Holzer Phil MSVP and Controller | Mar 10, 2025 | Mar 12, 2025 | A · derivative | 7,368 | $0.00 | $0 | 7,368 | No | Form 4 |
| Hoch LynellePresident, Cell Therapy Org. | Mar 10, 2025 | Mar 12, 2025 | M | 546 | $0.00 | $0 | 2,272 | No | Form 4 |
| Hoch LynellePresident, Cell Therapy Org. | Mar 10, 2025 | Mar 12, 2025 | J | 38 | $0.00 | $0 | 2,234 | No | Form 4 |
| Hoch LynellePresident, Cell Therapy Org. | Mar 10, 2025 | Mar 12, 2025 | F | 219 | $63.11 | $13,821 | 2,015 | No | Form 4 |
| Hoch LynellePresident, Cell Therapy Org. | Mar 10, 2025 | Mar 12, 2025 | M | 835 | $0.00 | $0 | 2,850 | No | Form 4 |
| Hoch LynellePresident, Cell Therapy Org. | Mar 10, 2025 | Mar 12, 2025 | J | 146 | $0.00 | $0 | 2,704 | No | Form 4 |
| Hoch LynellePresident, Cell Therapy Org. | Mar 10, 2025 | Mar 12, 2025 | F | 296 | $63.11 | $18,681 | 2,408 | No | Form 4 |
| Hoch LynellePresident, Cell Therapy Org. | Mar 10, 2025 | Mar 12, 2025 | M | 1,050 | $0.00 | $0 | 3,458 | No | Form 4 |
| Hoch LynellePresident, Cell Therapy Org. | Mar 10, 2025 | Mar 12, 2025 | J | 179 | $0.00 | $0 | 3,279 | No | Form 4 |
| Hoch LynellePresident, Cell Therapy Org. | Mar 10, 2025 | Mar 12, 2025 | F | 374 | $63.11 | $23,603 | 2,905 | No | Form 4 |
| Hoch LynellePresident, Cell Therapy Org. | Mar 10, 2025 | Mar 12, 2025 | M | 5,015 | $0.00 | $0 | 7,920 | No | Form 4 |
| Hoch LynellePresident, Cell Therapy Org. | Mar 10, 2025 | Mar 12, 2025 | J | 1,850 | $0.00 | $0 | 6,070 | No | Form 4 |
| Hoch LynellePresident, Cell Therapy Org. | Mar 10, 2025 | Mar 12, 2025 | F | 1,359 | $63.11 | $85,766 | 4,711 | No | Form 4 |
| Hoch LynellePresident, Cell Therapy Org. | Mar 10, 2025 | Mar 12, 2025 | M · derivative | 546 | $0.00 | $0 | not reported | No | Form 4 |
| Hoch LynellePresident, Cell Therapy Org. | Mar 10, 2025 | Mar 12, 2025 | M · derivative | 835 | $0.00 | $0 | 838 | No | Form 4 |
| Hoch LynellePresident, Cell Therapy Org. | Mar 10, 2025 | Mar 12, 2025 | M · derivative | 1,050 | $0.00 | $0 | 2,102 | No | Form 4 |
| Hoch LynellePresident, Cell Therapy Org. | Mar 10, 2025 | Mar 12, 2025 | A · derivative | 5,021 | $0.00 | $0 | 5,021 | No | Form 4 |
| Hoch LynellePresident, Cell Therapy Org. | Mar 10, 2025 | Mar 12, 2025 | M · derivative | 5,015 | $0.00 | $0 | not reported | No | Form 4 |
| Hoch LynellePresident, Cell Therapy Org. | Mar 10, 2025 | Mar 12, 2025 | A · derivative | 7,531 | $0.00 | $0 | 7,531 | No | Form 4 |
| Leung SandraEVP, General Counsel | Mar 10, 2025 | Mar 12, 2025 | M | 5,858 | $0.00 | $0 | 353,243.33 | No | Form 4 |
| Leung SandraEVP, General Counsel | Mar 10, 2025 | Mar 12, 2025 | J | 404 | $0.00 | $0 | 352,839.33 | No | Form 4 |
| Leung SandraEVP, General Counsel | Mar 10, 2025 | Mar 12, 2025 | F | 2,790 | $63.11 | $176,077 | 350,049.33 | No | Form 4 |
| Leung SandraEVP, General Counsel | Mar 10, 2025 | Mar 12, 2025 | M | 5,349 | $0.00 | $0 | 355,398.33 | No | Form 4 |
| Leung SandraEVP, General Counsel | Mar 10, 2025 | Mar 12, 2025 | J | 933 | $0.00 | $0 | 354,465.33 | No | Form 4 |
| Leung SandraEVP, General Counsel | Mar 10, 2025 | Mar 12, 2025 | F | 2,259 | $63.11 | $142,565 | 352,206.33 | No | Form 4 |
| Leung SandraEVP, General Counsel | Mar 10, 2025 | Mar 12, 2025 | M | 5,415 | $0.00 | $0 | 357,621.33 | No | Form 4 |
| Leung SandraEVP, General Counsel | Mar 10, 2025 | Mar 12, 2025 | J | 923 | $0.00 | $0 | 356,698.33 | No | Form 4 |
| Leung SandraEVP, General Counsel | Mar 10, 2025 | Mar 12, 2025 | F | 2,298 | $63.11 | $145,027 | 354,400.33 | No | Form 4 |
| Leung SandraEVP, General Counsel | Mar 10, 2025 | Mar 12, 2025 | M | 32,096 | $0.00 | $0 | 386,496.33 | No | Form 4 |
| Leung SandraEVP, General Counsel | Mar 10, 2025 | Mar 12, 2025 | J | 11,837 | $0.00 | $0 | 374,659.33 | No | Form 4 |
| Leung SandraEVP, General Counsel | Mar 10, 2025 | Mar 12, 2025 | F | 10,363 | $63.11 | $654,009 | 364,296.33 | No | Form 4 |
| Leung SandraEVP, General Counsel | Mar 10, 2025 | Mar 12, 2025 | M · derivative | 5,858 | $0.00 | $0 | not reported | No | Form 4 |
| Leung SandraEVP, General Counsel | Mar 10, 2025 | Mar 12, 2025 | M · derivative | 5,349 | $0.00 | $0 | 5,351 | No | Form 4 |
| Leung SandraEVP, General Counsel | Mar 10, 2025 | Mar 12, 2025 | M · derivative | 5,415 | $0.00 | $0 | 10,833 | No | Form 4 |
| Leung SandraEVP, General Counsel | Mar 10, 2025 | Mar 12, 2025 | A · derivative | 24,770 | $0.00 | $0 | 24,770 | No | Form 4 |
| Leung SandraEVP, General Counsel | Mar 10, 2025 | Mar 12, 2025 | M · derivative | 32,096 | $0.00 | $0 | not reported | No | Form 4 |
| Leung SandraEVP, General Counsel | Mar 10, 2025 | Mar 12, 2025 | A · derivative | 37,155 | $0.00 | $0 | 37,155 | No | Form 4 |
| Poole Ahn AmandaEVP, Chief People Officer | Mar 10, 2025 | Mar 12, 2025 | M | 690 | $0.00 | $0 | 3,114 | No | Form 4 |
| Poole Ahn AmandaEVP, Chief People Officer | Mar 10, 2025 | Mar 12, 2025 | J | 48 | $0.00 | $0 | 3,066 | No | Form 4 |
| Poole Ahn AmandaEVP, Chief People Officer | Mar 10, 2025 | Mar 12, 2025 | F | 233 | $63.11 | $14,705 | 2,833 | No | Form 4 |
| Poole Ahn AmandaEVP, Chief People Officer | Mar 10, 2025 | Mar 12, 2025 | M | 810 | $0.00 | $0 | 3,643 | No | Form 4 |
| Poole Ahn AmandaEVP, Chief People Officer | Mar 10, 2025 | Mar 12, 2025 | J | 141 | $0.00 | $0 | 3,502 | No | Form 4 |
| Poole Ahn AmandaEVP, Chief People Officer | Mar 10, 2025 | Mar 12, 2025 | F | 242 | $63.11 | $15,273 | 3,260 | No | Form 4 |
| Poole Ahn AmandaEVP, Chief People Officer | Mar 10, 2025 | Mar 12, 2025 | M | 803 | $0.00 | $0 | 4,063 | No | Form 4 |
| Poole Ahn AmandaEVP, Chief People Officer | Mar 10, 2025 | Mar 12, 2025 | J | 137 | $0.00 | $0 | 3,926 | No | Form 4 |
| Poole Ahn AmandaEVP, Chief People Officer | Mar 10, 2025 | Mar 12, 2025 | F | 241 | $63.11 | $15,210 | 3,685 | No | Form 4 |
| Poole Ahn AmandaEVP, Chief People Officer | Mar 10, 2025 | Mar 12, 2025 | M | 4,861 | $0.00 | $0 | 8,546 | No | Form 4 |
| Poole Ahn AmandaEVP, Chief People Officer | Mar 10, 2025 | Mar 12, 2025 | J | 1,793 | $0.00 | $0 | 6,753 | No | Form 4 |
| Poole Ahn AmandaEVP, Chief People Officer | Mar 10, 2025 | Mar 12, 2025 | F | 1,557 | $63.11 | $98,262 | 5,196 | No | Form 4 |
| Poole Ahn AmandaEVP, Chief People Officer | Mar 10, 2025 | Mar 12, 2025 | M · derivative | 690 | $0.00 | $0 | not reported | No | Form 4 |
| Poole Ahn AmandaEVP, Chief People Officer | Mar 10, 2025 | Mar 12, 2025 | M · derivative | 810 | $0.00 | $0 | 811 | No | Form 4 |
| Poole Ahn AmandaEVP, Chief People Officer | Mar 10, 2025 | Mar 12, 2025 | M · derivative | 803 | $0.00 | $0 | 1,608 | No | Form 4 |
| Poole Ahn AmandaEVP, Chief People Officer | Mar 10, 2025 | Mar 12, 2025 | A · derivative | 15,732 | $0.00 | $0 | 15,732 | No | Form 4 |
| Poole Ahn AmandaEVP, Chief People Officer | Mar 10, 2025 | Mar 12, 2025 | M · derivative | 4,861 | $0.00 | $0 | not reported | No | Form 4 |
| Poole Ahn AmandaEVP, Chief People Officer | Mar 10, 2025 | Mar 12, 2025 | A · derivative | 23,598 | $0.00 | $0 | 23,598 | No | Form 4 |
| Lenkowsky AdamEVP, Chief Commercial Officer | Mar 10, 2025 | Mar 12, 2025 | M | 1,904 | $0.00 | $0 | 8,554 | No | Form 4 |
| Lenkowsky AdamEVP, Chief Commercial Officer | Mar 10, 2025 | Mar 12, 2025 | J | 131 | $0.00 | $0 | 8,423 | No | Form 4 |
| Lenkowsky AdamEVP, Chief Commercial Officer | Mar 10, 2025 | Mar 12, 2025 | F | 907 | $63.11 | $57,241 | 7,516 | No | Form 4 |
| Lenkowsky AdamEVP, Chief Commercial Officer | Mar 10, 2025 | Mar 12, 2025 | M | 1,825 | $0.00 | $0 | 9,341 | No | Form 4 |
| Lenkowsky AdamEVP, Chief Commercial Officer | Mar 10, 2025 | Mar 12, 2025 | J | 318 | $0.00 | $0 | 9,023 | No | Form 4 |
| Lenkowsky AdamEVP, Chief Commercial Officer | Mar 10, 2025 | Mar 12, 2025 | F | 771 | $63.11 | $48,658 | 8,252 | No | Form 4 |
| Lenkowsky AdamEVP, Chief Commercial Officer | Mar 10, 2025 | Mar 12, 2025 | M | 2,000 | $0.00 | $0 | 10,252 | No | Form 4 |
| Lenkowsky AdamEVP, Chief Commercial Officer | Mar 10, 2025 | Mar 12, 2025 | J | 341 | $0.00 | $0 | 9,911 | No | Form 4 |
| Lenkowsky AdamEVP, Chief Commercial Officer | Mar 10, 2025 | Mar 12, 2025 | F | 849 | $63.11 | $53,580 | 9,062 | No | Form 4 |
| Lenkowsky AdamEVP, Chief Commercial Officer | Mar 10, 2025 | Mar 12, 2025 | M | 10,955 | $0.00 | $0 | 20,017 | No | Form 4 |
| Lenkowsky AdamEVP, Chief Commercial Officer | Mar 10, 2025 | Mar 12, 2025 | J | 4,040 | $0.00 | $0 | 15,977 | No | Form 4 |
| Lenkowsky AdamEVP, Chief Commercial Officer | Mar 10, 2025 | Mar 12, 2025 | F | 3,538 | $63.11 | $223,283 | 12,439 | No | Form 4 |
| Lenkowsky AdamEVP, Chief Commercial Officer | Mar 10, 2025 | Mar 12, 2025 | M · derivative | 1,904 | $0.00 | $0 | not reported | No | Form 4 |
| Lenkowsky AdamEVP, Chief Commercial Officer | Mar 10, 2025 | Mar 12, 2025 | M · derivative | 1,825 | $0.00 | $0 | 1,828 | No | Form 4 |
| Lenkowsky AdamEVP, Chief Commercial Officer | Mar 10, 2025 | Mar 12, 2025 | M · derivative | 2,000 | $0.00 | $0 | 4,001 | No | Form 4 |
| Lenkowsky AdamEVP, Chief Commercial Officer | Mar 10, 2025 | Mar 12, 2025 | A · derivative | 31,464 | $0.00 | $0 | 31,464 | No | Form 4 |
| Lenkowsky AdamEVP, Chief Commercial Officer | Mar 10, 2025 | Mar 12, 2025 | M · derivative | 10,955 | $0.00 | $0 | not reported | No | Form 4 |
| Lenkowsky AdamEVP, Chief Commercial Officer | Mar 10, 2025 | Mar 12, 2025 | A · derivative | 47,197 | $0.00 | $0 | 47,197 | No | Form 4 |
| Shanahan KarinEVP, Glob. Prod. Dev. & Supply | Mar 10, 2025 | Mar 12, 2025 | M | 2,447 | $0.00 | $0 | 7,783 | No | Form 4 |
| Shanahan KarinEVP, Glob. Prod. Dev. & Supply | Mar 10, 2025 | Mar 12, 2025 | J | 427 | $0.00 | $0 | 7,356 | No | Form 4 |
| Shanahan KarinEVP, Glob. Prod. Dev. & Supply | Mar 10, 2025 | Mar 12, 2025 | F | 1,034 | $63.11 | $65,256 | 6,322 | No | Form 4 |
| Shanahan KarinEVP, Glob. Prod. Dev. & Supply | Mar 10, 2025 | Mar 12, 2025 | M | 3,293 | $0.00 | $0 | 9,615 | No | Form 4 |
| Shanahan KarinEVP, Glob. Prod. Dev. & Supply | Mar 10, 2025 | Mar 12, 2025 | J | 561 | $0.00 | $0 | 9,054 | No | Form 4 |
| Shanahan KarinEVP, Glob. Prod. Dev. & Supply | Mar 10, 2025 | Mar 12, 2025 | F | 1,398 | $63.11 | $88,228 | 7,656 | No | Form 4 |
| Shanahan KarinEVP, Glob. Prod. Dev. & Supply | Mar 10, 2025 | Mar 12, 2025 | M | 14,683 | $0.00 | $0 | 22,339 | No | Form 4 |
| Shanahan KarinEVP, Glob. Prod. Dev. & Supply | Mar 10, 2025 | Mar 12, 2025 | J | 5,415 | $0.00 | $0 | 16,924 | No | Form 4 |
| Shanahan KarinEVP, Glob. Prod. Dev. & Supply | Mar 10, 2025 | Mar 12, 2025 | F | 4,741 | $63.11 | $299,205 | 12,183 | No | Form 4 |
| Shanahan KarinEVP, Glob. Prod. Dev. & Supply | Mar 10, 2025 | Mar 12, 2025 | M · derivative | 2,447 | $0.00 | $0 | 2,448 | No | Form 4 |
| Shanahan KarinEVP, Glob. Prod. Dev. & Supply | Mar 10, 2025 | Mar 12, 2025 | M · derivative | 3,293 | $0.00 | $0 | 6,587 | No | Form 4 |
| Shanahan KarinEVP, Glob. Prod. Dev. & Supply | Mar 10, 2025 | Mar 12, 2025 | A · derivative | 20,084 | $0.00 | $0 | 20,084 | No | Form 4 |
| Shanahan KarinEVP, Glob. Prod. Dev. & Supply | Mar 10, 2025 | Mar 12, 2025 | M · derivative | 14,683 | $0.00 | $0 | not reported | No | Form 4 |
| Shanahan KarinEVP, Glob. Prod. Dev. & Supply | Mar 10, 2025 | Mar 12, 2025 | A · derivative | 30,126 | $0.00 | $0 | 30,126 | No | Form 4 |
| Meyers Gregory ScottEVP, Chief Digital & Tech Off. | Mar 10, 2025 | Mar 12, 2025 | M | 2,836 | $0.00 | $0 | 9,832 | No | Form 4 |
| Meyers Gregory ScottEVP, Chief Digital & Tech Off. | Mar 10, 2025 | Mar 12, 2025 | J | 495 | $0.00 | $0 | 9,337 | No | Form 4 |
| Meyers Gregory ScottEVP, Chief Digital & Tech Off. | Mar 10, 2025 | Mar 12, 2025 | F | 994 | $63.11 | $62,731 | 8,343 | No | Form 4 |
| Meyers Gregory ScottEVP, Chief Digital & Tech Off. | Mar 10, 2025 | Mar 12, 2025 | M | 3,293 | $0.00 | $0 | 11,636 | No | Form 4 |
| Meyers Gregory ScottEVP, Chief Digital & Tech Off. | Mar 10, 2025 | Mar 12, 2025 | J | 561 | $0.00 | $0 | 11,075 | No | Form 4 |
| Meyers Gregory ScottEVP, Chief Digital & Tech Off. | Mar 10, 2025 | Mar 12, 2025 | F | 1,159 | $63.11 | $73,144 | 9,916 | No | Form 4 |
| Meyers Gregory ScottEVP, Chief Digital & Tech Off. | Mar 10, 2025 | Mar 12, 2025 | M | 17,021 | $0.00 | $0 | 26,937 | No | Form 4 |
| Meyers Gregory ScottEVP, Chief Digital & Tech Off. | Mar 10, 2025 | Mar 12, 2025 | J | 6,277 | $0.00 | $0 | 20,660 | No | Form 4 |
| Meyers Gregory ScottEVP, Chief Digital & Tech Off. | Mar 10, 2025 | Mar 12, 2025 | F | 4,558 | $63.11 | $287,655 | 16,102 | No | Form 4 |
| Meyers Gregory ScottEVP, Chief Digital & Tech Off. | Mar 10, 2025 | Mar 12, 2025 | M · derivative | 2,836 | $0.00 | $0 | 2,839 | No | Form 4 |
| Meyers Gregory ScottEVP, Chief Digital & Tech Off. | Mar 10, 2025 | Mar 12, 2025 | M · derivative | 3,293 | $0.00 | $0 | 6,587 | No | Form 4 |
| Meyers Gregory ScottEVP, Chief Digital & Tech Off. | Mar 10, 2025 | Mar 12, 2025 | A · derivative | 25,439 | $0.00 | $0 | 25,439 | No | Form 4 |
| Meyers Gregory ScottEVP, Chief Digital & Tech Off. | Mar 10, 2025 | Mar 12, 2025 | M · derivative | 17,021 | $0.00 | $0 | not reported | No | Form 4 |
| Meyers Gregory ScottEVP, Chief Digital & Tech Off. | Mar 10, 2025 | Mar 12, 2025 | A · derivative | 38,159 | $0.00 | $0 | 38,159 | No | Form 4 |
| Plenge Robert MEVP, Chief Research Officer | Mar 10, 2025 | Mar 12, 2025 | M | 1,165 | $0.00 | $0 | 12,480 | No | Form 4 |
| Plenge Robert MEVP, Chief Research Officer | Mar 10, 2025 | Mar 12, 2025 | J | 80 | $0.00 | $0 | 12,400 | No | Form 4 |
| Plenge Robert MEVP, Chief Research Officer | Mar 10, 2025 | Mar 12, 2025 | F | 482 | $63.11 | $30,419 | 11,918 | No | Form 4 |
| Plenge Robert MEVP, Chief Research Officer | Mar 10, 2025 | Mar 12, 2025 | M | 1,107 | $0.00 | $0 | 13,025 | No | Form 4 |
| Plenge Robert MEVP, Chief Research Officer | Mar 10, 2025 | Mar 12, 2025 | J | 193 | $0.00 | $0 | 12,832 | No | Form 4 |
| Plenge Robert MEVP, Chief Research Officer | Mar 10, 2025 | Mar 12, 2025 | F | 406 | $63.11 | $25,623 | 12,426 | No | Form 4 |
| Plenge Robert MEVP, Chief Research Officer | Mar 10, 2025 | Mar 12, 2025 | M | 2,342 | $0.00 | $0 | 14,768 | No | Form 4 |
| Plenge Robert MEVP, Chief Research Officer | Mar 10, 2025 | Mar 12, 2025 | J | 399 | $0.00 | $0 | 14,369 | No | Form 4 |
| Plenge Robert MEVP, Chief Research Officer | Mar 10, 2025 | Mar 12, 2025 | F | 862 | $63.11 | $54,401 | 13,507 | No | Form 4 |
| Plenge Robert MEVP, Chief Research Officer | Mar 10, 2025 | Mar 12, 2025 | M | 6,641 | $0.00 | $0 | 20,148 | No | Form 4 |
| Plenge Robert MEVP, Chief Research Officer | Mar 10, 2025 | Mar 12, 2025 | J | 2,449 | $0.00 | $0 | 17,699 | No | Form 4 |
| Plenge Robert MEVP, Chief Research Officer | Mar 10, 2025 | Mar 12, 2025 | F | 1,860 | $63.11 | $117,385 | 15,839 | No | Form 4 |
| Plenge Robert MEVP, Chief Research Officer | Mar 10, 2025 | Mar 12, 2025 | M · derivative | 1,165 | $0.00 | $0 | not reported | No | Form 4 |
| Plenge Robert MEVP, Chief Research Officer | Mar 10, 2025 | Mar 12, 2025 | M · derivative | 1,107 | $0.00 | $0 | 1,107 | No | Form 4 |
| Plenge Robert MEVP, Chief Research Officer | Mar 10, 2025 | Mar 12, 2025 | M · derivative | 2,342 | $0.00 | $0 | 4,684 | No | Form 4 |
| Plenge Robert MEVP, Chief Research Officer | Mar 10, 2025 | Mar 12, 2025 | A · derivative | 23,431 | $0.00 | $0 | 23,431 | No | Form 4 |
| Plenge Robert MEVP, Chief Research Officer | Mar 10, 2025 | Mar 12, 2025 | M · derivative | 6,641 | $0.00 | $0 | not reported | No | Form 4 |
| Plenge Robert MEVP, Chief Research Officer | Mar 10, 2025 | Mar 12, 2025 | A · derivative | 35,146 | $0.00 | $0 | 35,146 | No | Form 4 |
| Hickey BenjaminPresident, RayzeBio Org. | Mar 1, 2025 | Mar 4, 2025 | M | 3,286 | $0.00 | $0 | 10,419 | No | Form 4 |